Skip to content

Clinical trials

Completed Epilepsy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Status: Completed Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20091
20102
20123
20134
20144
20153
20163
20172
20182
20192
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB BIOSCIENCES, Inc.5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Eisai Inc.3
UCB Biopharma SRL3
UCB Pharma SA3
GlaxoSmithKline2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Shanghai Zhongshan Hospital2
Affiliated Hospital of Jiangnan University1
Beijing Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy36
Seizures11
Tuberous Sclerosis2
Autism Spectrum Disorder1
Brain Diseases1
Central Nervous System Diseases1
Cerebral Palsy1
Developmental Disabilities1
Down Syndrome1
Drug Resistant Epilepsy1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.